BiomX, Inc. Quarterly report pursuant to Section 13 or 15(d)

General (Details) - Schedule of Fair Value of the Consideration Transferred to APT Shareholders Acquisition $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)
Schedule of Fair Value of the Consideration Transferred to APT Shareholders Acquisition [Line items]
Total	$ 15,851
Common Stock [Member]
Schedule of Fair Value of the Consideration Transferred to APT Shareholders Acquisition [Line items]
Total	3,041
Redeemable Convertible Preferred Stock [Member]
Schedule of Fair Value of the Consideration Transferred to APT Shareholders Acquisition [Line items]
Total	12,610
Merger Warrants [Member]
Schedule of Fair Value of the Consideration Transferred to APT Shareholders Acquisition [Line items]
Total	$ 200